The Institute of Medical Science, The University Of Tokyo

NEWS

2024.10.29

A paper by Norifumi Iijima, Sub-project Leader of Laboratory of Biofunctional Molecular Medicine (formerly Sub-project Leader of Laboratory of Adjuvant Innovation) of the National Institute of Biomedical Innovation, Health and Nutrition (NIBIOHN), has been published in Journal of Autoimmunity.

 

miR-147-3p in pathogenic CD4 T cells controls chemokine receptor expression for the development of experimental autoimmune diseases

Iijima N, Yamaguchi M, Hayashi T, Rui Y, Ohira Y, Miyamoto Y, Niino M, Okuno T, Suzuki O, Oka M, Ishii KJ.
J Autoimmun. 2024 Oct 11;149:103319. doi: 10.1016/j.jaut.2024.103319.

Ishii's Laboratory

Division of Vaccine Science
The Institute of Medical Science, The University of Tokyo
4-6-1 Shirokanedai Minato-ku

vaccine★ims.u-tokyo.ac.jp※Please change ★ to @ and send